Professor Yvonne Perrie

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

In 1998, I gained my PhD from the University of London investigating the role of liposomes for drug delivery. I then moved to a newly established Drug Delivery Company (Lipoxen Technologies Ltd) for two years, developing their liposome drug delivery platform technology prior to moving to Academia to set up my own research group. I joined Aston University in 2000 and was appoint to Chair in Drug Delivery in 2007. I have effectively delivered in various academic and motivational leadership roles including Associate Dean for Learning and Teaching, Director of the Medicines Research Unit, and Head of Pharmacy.  In 2016, I moved to the University of Strathclyde at part of their Global Talent Appointment Programme where I am continuing to develop my research strategies.

My research is multi-disciplinary and is focused on the development of drug delivery systems to facilitate the delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems. I am an internationally recognised researcher with a strong track-record of high impact publications (current h-index 30), with approximately 100 peer reviewed manuscripts and 5 textbooks. To ensure the effective knowledge exchange and application of my research, I have generated 5 patents. My research and academic leadership has been recognised in a range of fellowships and awards including membership of the Controlled Release Society College of Fellows (2015), Fellow of the Royal Pharmaceutical Society (2014), Fellow of the Royal Society of Biology (2012), Eminent Fellow of the Academy of Pharmaceutical Sciences (2012), the Royal Pharmaceutical Society Pharmaceutical Scientist of the Year (2012), the British Science Festival Collaboration in Formulation Award (2011) and the Royal Pharmaceutical Society Science Conference Medal (2007). I maintain a steady funding stream to support my research team and I am funded through a range of sources including Government Research Councils, European Framework Funding, Industrial Partners and Charities (>£3.5 million in research funding). I have supervised 22 PhD students to successful completion (< 4 years), all of whom are now further developing their careers in either Academic or Industrial positions.  Externally I have numerous strategic leadership and advisory roles: I am an expert advisor for the MHRA, Chair of Pharmacy Schools Council (Jan 2014-2017) and I am Editor of the Controlled Release Society Newsletter (2004 – present). Previously I have been a Director-at-Large for the Controlled Release Society (3 years) and I completed 2 terms (6 years) as the Chair for the UK and Ireland Controlled Release Society. I am Editor in Chief of the Journal of Liposome Research and Pharmaceutics and Associate Editor for the Journal of Drug Targeting and the Journal of Pharmacy and Pharmacology.

Prizes and awards

Royal Pharmaceutical Society Harrison Medal
Recipient
31/7/2019
President-elect of the Controlled Release Society
Recipient
1/7/2019
Secretary for the Controlled Release Society
Recipient
2018
Science Chair: Improving Health: Personalisation or Globalisation? 46th Interpharm Conference
Recipient
2018
Science Chair: Reverse Engineering Shakespeare: Creating order and stability? 45th Interpharm Conference
Recipient
2017
50th Anniversary Chair in Drug Delivery
Recipient
1/11/2016

more prizes and awards

Publications

Freeze-drying cycle optimization for the rapid preservation of protein-loaded liposomal formulations
Hussain Maryam T, Forbes Neil, Perrie Yvonne, Malik Kiran P, Duru Chinwe, Matejtschuk Paul
International Journal of Pharmaceutics (2019)
Conceptualisation, development, fabrication and in vivo validation of a novel disintegration tester for orally disintegrating tablets
Koner Jasdip S, Rajabi-Siahboomi Ali R, Missaghi Shahrzad, Kirby Daniel, Perrie Yvonne, Ahmed Jiteen, Mohammed Afzal R
Scientific Reports Vol 9 (2019)
https://doi.org/10.1038/s41598-019-48859-x
Scale-independent microfluidic production of cationic liposomal adjuvants and development of enhanced lymphatic targeting strategies
Roces Carla B, Khadke Swapnil, Christensen Dennis, Perrie Yvonne
Molecular Pharmaceutics (2019)
https://doi.org/10.1021/acs.molpharmaceut.9b00730
A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes : formulation, cellular uptake and biodistribution investigations
Lou Gustavo, Anderluzzi Giulia, Woods Stuart, Roberts Craig W, Perrie Yvonne
European Journal of Pharmaceutics and Biopharmaceutics Vol 143, pp. 51-60 (2019)
https://doi.org/10.1016/j.ejpb.2019.08.013
Formulation and manufacturing of lymphatic targeting liposomes using microfluidics
Khadke Swapnil, Roces Carla B, Cameron Allan, Devitt Andrew, Perrie Yvonne
Journal of Controlled Release Vol 307, pp. 211-220 (2019)
https://doi.org/10.1016/j.jconrel.2019.06.002
Liposomes : a promising carrier for respiratory syncytial virus therapeutics
Joshi Sameer, Bawage Swapnil, Tiwari Pooja, Kirby Daniel, Perrie Yvonne, Dennis Vida, Singh Shree R
Expert Opinion on Drug Delivery Vol 16, pp. 969-980 (2019)
https://doi.org/10.1080/17425247.2019.1652268

more publications

Projects

Microfluidic-assisted manufacture of self-assembling silk nanoparticles
Seib, Philipp (Principal Investigator) Perrie, Yvonne (Co-investigator)
01-Jan-2019 - 30-Jan-2023
One-step and scalable manufacture of lymphatic-targeting liposomal vaccines.
Perrie, Yvonne (Principal Investigator)
01-Jan-2018 - 30-Jan-2022
David Begg / NSF Studentship | Webb, Cameron
Perrie, Yvonne (Principal Investigator) MacKay, Simon (Co-investigator) Webb, Cameron (Research Co-investigator)
01-Jan-2018 - 01-Jan-2021
Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines PHA-ST-TRAIN-VAC (H2020 MCSA EID) | Lou Ramirez, Gustavo
Perrie, Yvonne (Principal Investigator) Roberts, Craig (Co-investigator) Lou Ramirez, Gustavo (Research Co-investigator)
01-Jan-2017 - 01-Jan-2020
Microfluidic manufacturing and development of a novel clostridium difficile oral vaccine | Forbes, Neil Liam Andrew
Perrie, Yvonne (Principal Investigator) Hoskisson, Paul (Co-investigator) Forbes, Neil Liam Andrew (Research Co-investigator)
01-Jan-2016 - 01-Jan-2020
Microfluidic manufacturing and development of a novel clostridium difficile oral vaccine
Perrie, Yvonne (Principal Investigator)
26-Jan-2016 - 25-Jan-2020

more projects

Address

Strathclyde Institute of Pharmacy and Biomedical Sciences
Robertson Wing

Location Map

View University of Strathclyde in a larger map